Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Tivdak
Pharma
Genmab shuffles C-Suite as portfolio grows
Genmab is revamping its executive team as the Danish antibody specialist looks to evolve into “a fully integrated biotech innovation powerhouse.”
Angus Liu
Aug 19, 2024 10:08am
ESMO: Seagen, Genmab's Tivdak excel in cervical cancer study
Oct 22, 2023 10:30am
Seagen, Genmab's Tivdak meets goals in cervical cancer trial
Sep 5, 2023 11:10am
Seagen, Genmab run 'CeMe' cervical cancer campaign
Feb 10, 2022 10:34am
Seagen, Genmab's cervical cancer med Tivdak scores FDA nod
Sep 21, 2021 10:00am
